Brief: Aap Receives Approval For Clinical Study Of Antibacterial Silver Coating

aap Implantate AG

23/04/2020 11:44

April 23 (Reuters) - AAP IMPLANTATE AG  AAQG.DE :
    * RECEIVES APPROVAL FROM ETHICS COMMISSIONS FOR HUMAN
CLINICAL
STUDY FOR INNOVATIVE ANTIBACTERIAL SILVER COATING TECHNOLOGY;
ALL REGULATORY REQUIREMENTS FOR STARTING STUDY IN GERMANY
FULFILLED
    * CAN INITIALLY DRAW ON FURTHER FUNDING FROM GERMAN FEDERAL
MINISTRY OF EDUCATION AND RESEARCH ("BMBF")
    * HAS BEEN GRANTED UP TO APPROXIMATELY EUR 2.7 MILLION TO
COVER
EXPENSES INCURRED BY CARRYING OUT STUDY
    * IN TALKS WITH INTERESTED GLOBAL MEDICAL TECHNOLOGY
COMPANIES
ABOUT POTENTIAL CO-FINANCING AND OTHER COOPERATION OPTIONS

Source text for Eikon:  ID:nEQbYyxFga 
Further company coverage:  AAQG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))